48317770967_48ec28d656_b

Trump meets pharmaceutical executives to discuss COVID-19 vaccine

pharmafile | March 4, 2020 | News story | Research and Development COVID-19, Chinese Coronavirus, Trump, Wuhan Coronavirus, coronavirus 

President Trump has met with several representatives of the top pharmaceutical companies to discuss progress being made on a coronavirus vaccine.

Executives from Gilead Sciences, GlaxoSmithKline, Inovio pharmaceuticals, Moderna and Regeneron Pharmaceuticals were all in attendance.

Commenting on the gathering, Trump said: “They’re really working hard and they’re working smart. We had a great meeting with a lot of great companies. They’re going to have vaccines, I think, relatively soon, and they’re going to have something that makes you better, and that’s actually going to take place even sooner. I don’t know what the time will be. I’ve heard very quick numbers, that of months. And I’ve heard pretty much a year would be an outside number.”

However, Trump’s timeline does not seem realistic and Antony Fauci, the head of the National Institute of Allergy and Infectious Diseases, said that a deployable vaccine is “going to be, at the earliest, a year to a year and a half.” This is backed up by the pharmaceutical companies with John Shiver, Senior Vice President of global vaccine R&D at Sanofi, who also attended the meeting, saying that a therapeutic for the virus could be developed “months or a very short amount of time, a year or so.”

Gilead’s drug remdesivir, originally developed for Ebola, has been tested since January on coronavirus patients and is currently in clinical trials.

Conor Kavanagh

 

Related Content

diana-polekhina-zbsthwt9vlc-unsplash_2

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

AstraZeneca has announced positive high-level results from the SUPERNOVA phase 3 trial for a COVID-19 …

Vaccine image

Sanofi and Novavex sign exclusive $1.2bn licensing agreement to co-commercialise COVID-19 vaccine and develop flu-COVID-19 vaccines

French pharma and healthcare company Sanofi and US biotech Novavex, have entered into a co-exclusive …

az_vaccine

AstraZeneca withdraws COVID-19 vaccine Vaxzevria

UK-based pharmaceutical company AstraZeneca has announced that is it voluntarily withdrawing its COVID-19 vaccine Vaxzevria …

Latest content